| Abstrakt: |
A recent report from researchers at the School of Medical Sciences in Manchester, United Kingdom discusses the therapeutic targeting of DNA repair pathways in cancer treatment. The researchers focused on a small molecule called UNC3866, which targets CBX4, a protein involved in DNA repair. They found that treatment with UNC3866 sensitizes certain types of cancer cells to radiation, while being non-toxic to other cells. This research suggests that UNC3866 could be a potential treatment option for HR-ineffective cancers. [Extracted from the article] |
